Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Globalstar heads into its November earnings with an unusual ownership story front and centre, one where the clearest signal comes not from short sellers or options desks but from a pair of directors effectively swapping $30 million of stock across the same settlement date.
On September 18, director James Lynch sold 361,600 shares at $82.52, pocketing nearly $29.8 million. On the same day, James Monroe III, the company's largest shareholder and a Schedule 13D filer with activist status, bought the same number of shares at the same price for the same dollar amount. Monroe, who already controlled roughly 57.4% of shares outstanding, added to that position without a pre-arranged 10b5-1 plan. An activist buyer absorbing a director's entire block at market prices, without hedging mechanics, is a straightforward statement of conviction from the one insider who matters most in the cap table. Monroe's 13D filing, last updated in April, carries the standard caveat that stakes are as-last-disclosed around the 5% threshold, but at 57% of the company his position is not one that changes quietly. The net insider picture over the past 90 days is negative on a shares basis, largely because Lynch's sale dominates the arithmetic. Strip that transaction out and the registered insider buying from Monroe tells a different story.
The lending market offers no drama to complement the boardroom activity. Borrow is effectively free at 0.41% and availability is running at roughly 1,792%, meaning there are around 18 shares available to lend for every one currently borrowed. Short interest is 3.5% of the free float, down fractionally on the week after rising about 14% over the past month. That monthly build is worth watching, but at current levels and with availability this loose, there is no squeeze dynamic in play. The ORTEX short score is sitting at 50, squarely neutral, consistent with a stock where bears have added modestly but face no structural pressure in the borrow market.
Options positioning is similarly unexciting. The put/call ratio is 0.53, almost exactly in line with its 20-day average of 0.54 and a full standard deviation below the 52-week high of 0.84. Calls are running about twice as heavy as puts on a relative basis. That is not a defensive setup; if anything it tilts slightly constructive, though the z-score of -0.17 flags the move as statistically unremarkable.
The Street's read on GSAT is thin and, frankly, dated. The consensus sits at hold from three analysts, with one buy. The most recent target changes on record are from late 2025, when B. Riley lifted its target to $75 and Clear Street initiated at $66 with a buy, both well below the current $83.66. Those targets are now stale relative to the stock's move and should be treated as historical context rather than current guidance. The valuation reflects a company still growing into its price: a trailing P/E of 275, EV/EBITDA of 65, and a price-to-book of 28. The EV/EBIT factor score ranks in the second percentile of the universe, a reminder that GSAT carries satellite-infrastructure economics, heavy capital, thin near-term earnings, and a market pricing in a much larger business than today's income statement reflects. One genuinely strong factor is earnings surprise, which ranks in the 93rd percentile, suggesting the company has a habit of beating what little the Street formally models.
Retail attention spiked recently, with ORTEX's Wikipedia-views signal registering a z-score of 3.6 against the company's own 90-day history as of late September. Spikes in retail attention at that level often accompany news flow or social media momentum rather than fundamental shifts, and the stock has only moved 1.3% on the week and 1.6% over the past month, suggesting the attention has not (yet) translated into sustained price action.
Among the closest correlated peers, TSAT gained 4% on the week and LUMN was up 6.7%, while GSAT's 1.3% gain lagged both. The divergence is modest but worth noting given GSAT's recent momentum credentials.
The November 6 earnings date is the next hard event on the calendar. Prior prints have been quiet affairs: the stock moved less than 1% the day after each of the last four releases. Whether Monroe's September block purchase reflects positioning ahead of that report or simply longer-term capital allocation is the question the market will chew on between now and then.
See the live data behind this article on ORTEX.
Open GSAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
